secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001808805-25-000082
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus regains Nasdaq minimum bid price compliance; deficiency closed
-----------------------------------------------------------------------

- Received notice on Nov 3, 2025 that closing bid price met $1 for 10 consecutive days.
- Deficiency previously disclosed May 2, 2025; compliance period extended to April 27, 2026.
- Company transferred to Nasdaq Capital Market on Oct 29, 2025 to utilize second compliance period.
- Matter now closed; no further action required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/0001808805-25-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/naut-20251103.htm
  HTML page:      https://secwatch.observer/filing/0001808805-25-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer